NCT00283478 Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase NA
NCT00281996 Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic Cancer Status TERMINATED Phase PHASE1
NCT00280878 Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma Status COMPLETED Phase PHASE2
NCT00276744 Individualized Drug Treatment for Treating Patients With Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT00270907 CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT00268840 The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer Status COMPLETED Phase PHASE2
NCT00267696 Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT00267020 Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00256295 Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer Status TERMINATED Phase PHASE2
NCT00254904 Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC Status TERMINATED Phase PHASE3
NCT00251355 Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT00248560 Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00247416 Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer Status COMPLETED Phase PHASE2
NCT00244933 Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer Status COMPLETED Phase PHASE2
NCT00242190 Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00237575 Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer Status TERMINATED Phase PHASE3
NCT00236899 Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBC Status COMPLETED Phase PHASE3
NCT00235235 A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer Status TERMINATED Phase N/A